Contract facts
FederalMeeting, Scientific, and Administration Support Services (MSASS) for Congressionally Directed Medical Research Program… is a federal award for W4pz Usa Med Rsch Acquis Act held by Leidos, Inc. Estimated value $2M ($1M obligated). Current period of performance ends Feb 28, 2023 (potential Aug 30, 2023). Place of performance: FREDERICK MD. Related solicitation W81XWH17R0036.
Meeting, scientific, and administration support services (msass) for congressionally directed medical research program (cdmrp)- general program support. Latest action is a modification.
Recompete timing
PublicCurrent PoP ended Feb 28, 2023 (1331 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on W81XWH22F0237? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordLeidos, Inc — $3.2B obligated across 1,081 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract W81XWH22F0237?
W81XWH22F0237 (MSASS and support services) is a W4pz Usa Med Rsch Acquis Act award with a potential value of $2M, currently held by Leidos, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is W81XWH-22-F-0237?
W81XWH-22-F-0237 is the dashed form of PIID W81XWH22F0237 (MSASS and support services), held by Leidos, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded W81XWH22F0237?
W4pz Usa Med Rsch Acquis Act awarded W81XWH22F0237 to Leidos, Inc (potential $2M).
Who is the incumbent on W81XWH22F0237?
Leidos, Inc is the incumbent with $3.2B across 1081 related awards in SCOUT’s public footprint. The current period of performance ends Feb 28, 2023.
When does Leidos, Inc’s W81XWH22F0237 come up for recompete?
SCOUT tracks a period-of-performance end of Feb 28, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on W81XWH22F0237? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.